Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 11th:
PBF Energy Inc. (PBF - Free Report) : This company that engages in refining and supplying petroleum products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.6% over the last 60 days.
PBF’ shares gained 14.7% over the last three months compared with the S&P 500’s decline of 1.6%. The company possesses a Momentum Score of A.
Praxis Precision Medicines, Inc. (PRAX - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 15% over the last 60 days.
Praxis’s shares gained 9.2% over the last three months compared with the S&P 500’s decline of 1.6%. The company possesses a Momentum Score of A.
Catalyst Pharmaceuticals, Inc. (CPRX - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.4% over the last 60 days.
Catalyst’s shares gained 0.8% over the last three months compared with the S&P 500’s decline of 1.6%. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.2% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 11th:
PBF Energy Inc. (PBF - Free Report) : This company that engages in refining and supplying petroleum products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.6% over the last 60 days.
PBF’ shares gained 14.7% over the last three months compared with the S&P 500’s decline of 1.6%. The company possesses a Momentum Score of A.
Praxis Precision Medicines, Inc. (PRAX - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 15% over the last 60 days.
Praxis’s shares gained 9.2% over the last three months compared with the S&P 500’s decline of 1.6%. The company possesses a Momentum Score of A.
Catalyst Pharmaceuticals, Inc. (CPRX - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.4% over the last 60 days.
Catalyst’s shares gained 0.8% over the last three months compared with the S&P 500’s decline of 1.6%. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.2% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Get the latest research report on PBF - FREE
Get the latest research report on CPRX - FREE
Get the latest research report on PRAX - FREE